Robin Vacha - 31 Jan 2024 Form 4 Insider Report for Azenta, Inc. (AZTA)

Role
SVP, GM Life Science Products
Signature
/s/Jason W. Joseph, Attorney-in-fact for Robin Vacha
Issuer symbol
AZTA
Transactions as of
31 Jan 2024
Net transactions value
+$8,005
Form type
4
Filing time
02 Aug 2024, 16:05:03 UTC
Previous filing
06 Dec 2023
Next filing
02 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AZTA Common Award $8,005 +151 +0.48% $53.01 31,438 31 Jan 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Purchase by Reporting Person under the Azenta, Inc. 2017 Employee Stock Purchase Plan. The purchase of shares was exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Exchange Act") pursuant to Rule 16b-3(c) under the Exchange Act